Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Blood Loss
- Pituitary Tumor
- Surgery
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Participants randomized to receive the investigational product vs placebo during a single study encounter.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: The only staff with access to randomization codes will be our study statistician who created the randomization table and our investigational drug services pharmacy who is preparing the investigational product.Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04863339
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Brent Senior, MD UNC Chapel Hill
Get Well Soon